以更便宜的重量损失药物Ozempic为首的超级碗广告《Hims & hers》面临强烈反弹, Hims & Hers faces backlash for Super Bowl ad of cheaper version of weight-loss drug Ozempic, drawing FDA rule scrutiny.

《Hims & Hers》是一家数字保健公司, 在其超级碗广告上遭到制药业的批评, Hims & Hers, a digital health company, faces criticism from the pharmaceutical industry over its Super Bowl ad for an off-brand version of the weight-loss drug Ozempic. 美国食品药品管理局要求禁止该广告. The Partnership for Safe Medicines claims the ad violates FDA rules and has asked the FDA to block it. Hims & Hers认为广告强调了行业对利润的关注,指出其产品与Ozempic具有相同的活性成分,但价格较低。 Hims & Hers argues the ad highlights industry profit concerns, noting its product has the same active ingredient as Ozempic but at a lower price.